Coverage With Evidence Development: Where Are We Now?
Review of CMS’ coverage with evidence development program exposes a need to improve program transparency and clarify requirements and timetables for reporting to improve access to novel therapies.
Imagining a World Without Low-Value Services: Progress, Barriers, and the Path Forward
Clinician-, patient-, and research-focused initiatives are needed to reduce the delivery of low-value care services that contribute to financial, clinical, and psychological harm for patients.
Accountable Care Organizations Are Increasingly Led by Physician Groups Rather Than Hospital Systems
Since 2015, the majority of new accountable care organizations (ACOs) have been led by physician groups rather than hospital systems. This shift requires policies that address the characteristic strengths and weaknesses of physician-led ACOs.
ACOs With Risk-Bearing Experience Are Likely Taking Steps to Reduce Low-Value Medical Services
Experience with risk-based contracting best predicts active engagement of accountable care organizations in reducing low-value medical services, mainly through physician education and encouraging shared decision making.
Forgotten Patients: ACO Attribution Omits Those With Low Service Use and the Dying
This article compares clinical and utilization profiles of Medicare patients who are attributed to provider groups with those of patients unattributed to any provider group in accountable care organization models.
Overuse and Insurance Plan Type in a Privately Insured Population
Health insurance plan type may be an important lever for reducing low-value healthcare use among patients with commercial insurance.
Measuring Overuse With Electronic Health Records Data
Electronic health records data can accurately quantify overuse of clinical services and the risk factors that may trigger low-value testing and screening.
Physician Perceptions of Choosing Wisely and Drivers of Overuse
The authors surveyed physicians regarding “Choosing Wisely” and hypothesized drivers of overuse, finding high reported prevalence of hypothesized drivers of overuse and widespread support for cost-consciousness.
ACO Contracting With Private and Public Payers: A Baseline Comparative Analysis
The authors find 51% of accountable care organizations have private payer contracts, which are more likely than public contracts to include downside risk and upfront payments.
Tracking Spending Among Commercially Insured Beneficiaries Using a Distributed Data Model
The authors demonstrate the utility of distributed data models for reporting of local trends and variation in utilization, pricing, and spending for commercially insured beneficiaries.
Impact of Payment Reform on Chemotherapy at the End of Life
Payment reform may be used to better align appropriate financial incentives with better quality of care.
2 Commerce Drive Cranbury, NJ 08512